Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Withdrawal of Steroids or Tacrolimus in Kidney Transplant
NCT00195429Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplant rejection (2 arms), sponsored by Pfizer. Primary endpoint: Number of Patients With Biopsy Confirmed Acute Rejection at 12 months. Started Aug 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00195429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195429.